Stocks and Investing Stocks and Investing
Thu, November 3, 2022
Wed, November 2, 2022

Gregory Renza Maintained (APTO) at Buy with Decreased Target to $75 on, Nov 2nd, 2022


Published on 2024-10-27 23:51:47 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Decreased Target from $90 to $75 on, Nov 2nd, 2022.

Gregory, nor any peers, have made any analyst calls on APTO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30